Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors.
Saved in:
| Title: | Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors. |
|---|---|
| Authors: | Halmos B; Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States., Rai P; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Min J; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Hu X; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Chirovsky D; Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States., Shamoun M; Clinical Research, Merck & Co., Inc., Rahway, NJ, United States., Zhao B; Clinical Research, Merck & Co., Inc., Rahway, NJ, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Apr 18; Vol. 14, pp. 1285280. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2024.1285280 |
